Global Contact Layer Dressings Market Report 2023-2030: Focus on Region, Country-Level Analysis, and Competitive Landscape
08 mai 2024 05h01 HE
|
Research and Markets
Dublin, May 08, 2024 (GLOBE NEWSWIRE) -- The "Contact Layer Dressings Market - A Global and Regional Analysis: Focus on Region, Country-Level Analysis, and Competitive Landscape - Analysis and...
Coloplast Finance B.V. - Interim Financial Report, H1 2023/24
07 mai 2024 03h51 HE
|
Coloplast Finance B.V.
H1 2023/24Interim financial results, H1 2023/241 October 2023 - 31 March 2024 Coloplast delivered a solid Q2 with 8% organic growth and an EBIT margin1) of 27%. Reported revenue in DKK grew 9% with...
Coloplast A/S - Selskabsmeddelelse nr. 02/2024 - Regnskabsmeddelelse, 1. halvår 2023/24
07 mai 2024 01h00 HE
|
Coloplast A/S
H1 2023/24Regnskabsmeddelelse, 1. halvår 2023/241. oktober 2023 – 31. marts 2024 Coloplast leverede et solidt 2. kvartal med 8% organisk vækst og en overskudsgrad1) på 27%. Den rapporterede...
Coloplast A/S - Announcement no. 02/2024 - Interim Financial Report, H1 2023/24
07 mai 2024 01h00 HE
|
Coloplast A/S
H1 2023/24Interim financial results, H1 2023/241 October 2023 - 31 March 2024 Coloplast delivered a solid Q2 with 8% organic growth and an EBIT margin1) of 27%. Reported revenue in DKK grew...
Tissue Engineered Skin Substitute Market Projected to Reach US$ 3.5 Billion by 2034 | Future Market Insights, Inc.
08 avr. 2024 09h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, April 08, 2024 (GLOBE NEWSWIRE) -- The tissue engineered skin substitute market is expected to reach a value of US$ 2.4 billion in 2024, with projections indicating a growth to US$ 3.5...
Coloplast Finance B.V. - Interim Financial Report, Q1 2023/24
09 févr. 2024 07h04 HE
|
Coloplast Finance B.V.
Q1 2023/24Interim financial results, Q1 2023/241 October 2023 - 31 December 2023 Coloplast delivered a solid Q1 with 8% organic growth and an EBIT margin1) of 28%. Reported revenue in DKK grew 8%...
Coloplast A/S - Regnskabsmeddelelse, Q1 2023/24
09 févr. 2024 01h30 HE
|
Coloplast A/S
Q1 2023/24Delårsrapport, 1. kvartal 2023/241. oktober 2023 – 31. december 2023 Coloplast leverede et solidt 1. kvartal med 8% organisk vækst og en overskudsgrad1) på 28%. Den rapporterede...
Coloplast A/S - Interim Financial Report, Q1 2023/24
09 févr. 2024 01h30 HE
|
Coloplast A/S
Q1 2023/24Interim financial results, Q1 2023/241 October 2023 - 31 December 2023 Coloplast delivered a solid Q1 with 8% organic growth and an EBIT margin1) of 28%. Reported...
Sjóvá – Ársuppgjör 2023
08 févr. 2024 10h48 HE
|
Sjóvá-Almennar tryggingar hf.
Helstu niðurstöður úr ársuppgjöri Sjóvá-Almennra trygginga hf. fyrir árið 2023 4.626 m.kr. hagnaður og samsett hlutfall 94,6% á árinu 2023 Fjórði ársfjórðungur 2023 Hagnaður af...
Skin Grafting Devices Global Market is Projected to Grow at a CAGR of ~7% by 2028 | DelveInsight
11 janv. 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Skin Grafting Devices Global Market is Projected to Grow at a CAGR of ~7% by 2028 | DelveInsight The skin grafting devices market is witnessing...